At PHC Group, we believe that nothing is more valuable than health. For 50 years we have been providing innovative precision and digital health solutions that advance the research, diagnosis, treatment, and prevention of disease.
Every day, in more than 125 countries and regions around the world, PHC Group companies are sharing ideas and resources across our interconnected businesses. As “One PHC,” our trusted brands are working to bring quality and innovation at every step in the healthcare journey.
- In our Diabetes Management Domain, Ascensia Diabetes Care provides cutting-edge glucose monitoring technology to simplify the way people with diabetes manage their health. Our blood glucose monitoring products are used by an estimated 10 million people worldwide. As the market shifts to continuous glucose monitoring, we have partnered with Senseonics to deliver the world’s first longterm implantable CGM, offering flexibility and peace of mind for people with diabetes.
- In our Healthcare Solutions Domain, Wemex has Japan’s largest market share for medical-receipt computers and electronic medical record systems in clinics and pharmacies. We will continue to drive digital transformation in medical care through telemedicine and medical data innovation. LSI Medience provides services in clinical testing through analysis, including cancer diagnostics, genetic testing, and sports doping testing, while Mediford corporation supports a wide range of research and drug development, from basic development to clinical trials.
- In our Diagnostics and Life Sciences Domain, we contribute to the early detection and treatment of disease. Epredia offers precision cancer diagnostic solutions to improve the laboratory workflow and support more efficient and accurate decisions. PHCbi awardwinning ultra-low temperature freezers support research laboratories with industry-leading energy-saving performance. Our PHC IVD contributes to real-time through its highly accurate diagnostic and its compact POCT (point of care testing device).
PHC Group companies and brands are constantly innovating products that drive scientific research to develop the next generation of treatments. Together, PHC Group companies take on healthcare challenges to solve significant unmet need and to enhance the quality, accessibility, and cost-effectiveness of care.
On behalf of PHC Group, thank you for your interest in our companies. We are proud to be your partner in delivering precision technology for the future of health.
Kyoko Deguchi
President, Representative Director and CEO
PHC Holdings Corporation